Fig. 4.

Patient (Case No. 2) treated with surgical resection and flap reconstruction followed by adjuvant HDRBT for treatment of a primary left sub-scapular synovial sarcoma. (A) Resection defect of left scapula. (B) Catheter placement and latissimus dorsi myocutaneous rotational flap reconstruction. (C) 6 month follow-up appointment. The patient did not experience any wound healing toxicity. (D) Grade 2 joint-function toxicity, with > 25% impairment in range of motion and no interference in activities of daily living 6 months after completion of HDRBT